Company Short-Term Debts: Checkpoint Therapeutics, Inc. (CKPT)

Graphic logo of Checkpoint Therapeutics (CKPT)

The price characteristics for Checkpoint Therapeutics (CKPT) on the GURU.Markets platform are 0.00, which accompanies the activities of Checkpoint Therapeutics (CKPT). The business relies on a virtual management model, attracting experts through option programs and outsourced development. Checkpoint Therapeutics (CKPT) diversifies risks by creating targeted drugs for lung and skin therapy. Currently, the antibody ecosystem is facing FDA delays due to external manufacturing audits, which temporarily limits commercialization.

Company Short-Term Loans and Borrowings: Checkpoint Therapeutics Inc. (CKPT) for 07/04/2022 - 06/07/2025

CKPT (Checkpoint Therapeutics Inc): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price Checkpoint Therapeutics, Inc.|CKPT - Consensus Target
- market capitalization data:
Market Capitalization Checkpoint Therapeutics, Inc.|CKPT - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Checkpoint Therapeutics|CKPT - Accounting Value of Company|Market Cap to Net Assets Ratio checkpointtx.com|CKPT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Checkpoint Therapeutics|CKPT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Checkpoint Therapeutics|CKPT - Company Aggregate Debts|Debt to Book Capitalization Ratio Checkpoint Therapeutics, Inc.|CKPT - Company Long-Term Loans and Borrowings|Company Short-Term Debts Checkpoint Therapeutics
Fundamental company valuation:CKPT Checkpoint Therapeutics, Inc.
Flagship merchandise of checkpointtx.com

The efficiency of outsourcing synthesis and testing at Checkpoint Therapeutics (CKPT) depends directly on the liquidity available to pay external vendors. This metric measures the daily load of obligations for up to one year, determining the balance between expansion and the risk of a cash crunch, which allows for an assessment of the issuer's financial stability through short-term borrowing volume.

Competitors of Checkpoint Therapeutics (CKPT)

ONC: Company Short-Term Debts|HALO - Company Current Liabilities|Company Short-Term Debts RVMD|AAPG (Ascentage Pharma Corp) - Short-Term Debt|CGON - Company Short-Term Debt|Company Short-Term Loans and Borrowings urogen.com (URGN)|Bicara Therapeutics (BCAX) - Company Current Liabilities|Company Short-Term Loans and Borrowings Personalis Inc (PSNL)|Erasca Corp - Company Short-Term Debts|DCTH - Company Current Liabilities|Y-mAbs Therapeutics - Company Current Liabilities|AURA: Company Short-Term Debts|Company Short-Term Debt candeltx.com CADL|Accuray Inc (ARAY) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SLS (SELLAS Life Sciences Group, Inc.)|Short-Term Debt Actuate Therapeutics Inc|Company Short-Term Debts CTOR (Citius Oncology, Inc.)|Company Current Liabilities tuhurabio.com (HURA)|Company Short-Term Debts Protara Therapeutics, Inc.|Company Short-Term Loans and Borrowings Fate Therapeutics Inc FATE|WHWK (Aadi Bio) - Company Short-Term Debts|TCRX - Short-Term Debt|CSBR (championsoncology.com) - Company Short-Term Debts|XBIT (XBiotech) - Company Current Liabilities|CVM (CEL-SCI Corp.) - Company Short-Term Debt|Company Short-Term Debts OSTX|RADX - Company Short-Term Debt|Current Liabilities ARTV (artivabio.com)|ANL: Company Short-Term Debt|Short-Term Debt verupharma.com VERU|Company Short-Term Debts TPST (Tempest Therapeutics, Inc.)|XLO: Short-Term Debt Volume|Company Short-Term Debt renovarobio.com|Company Short-Term Indebtedness Mural Oncology|Kairos Pharma Limited (KAPA) - Company Current Liabilities|Amount of Current Liabilities OnKure (OKUR)|CytoMed Therapeutics (GDTC) - Company Current Liabilities|Company Short-Term Loans and Borrowings curis.com CRIS|Company Current Liabilities Apollomics (APLM)|Amount of Current Liabilities Tharimmune Corporation THAR|Company Short-Term Debts Advanced Biomed Corp (ADVB)|GNPX - Company Short-Term Loans and Borrowings|Company Short-Term Debts CLDI|SBFM (sunshinebiopharma.com) - Short-Term Debt|XBIO - Company Short-Term Debt|Company Short-Term Loans and Borrowings Salarius Pharma|Company Short-Term Debts PPBT|Company Short-Term Debts AONC (aoncology.com)|BeiGene (BGNE) - Company Short-Term Debt|Current Liabilities Elevation Oncology Inc. ELEV|ICAD (iCAD Corp) - Company Short-Term Debts|Ikena Oncology, Inc. (IKNA) - Short-Term Debt|NTBL: Company Current Liabilities|Company Short-Term Debts Viracta Therapeutics, Inc.|MorphoSys (MOR) - Company Current Liabilities|Amount of Current Liabilities NAYA Biosciences Inc|AAPGV (Ascentage Pharma Group Ltd) - Company Short-Term Debts